Cite
Defining conditions for biofilm inhibition and eradication assays for Gram-positive clinical reference strains
MLA
Shreya Shah, et al. Defining Conditions for Biofilm Inhibition and Eradication Assays for Gram-Positive Clinical Reference Strains. Nov. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b700706924db4295a435f388a8a3c3b6&authtype=sso&custid=ns315887.
APA
Shreya Shah, Päivi Tammela, & Cristina D. Cruz. (2018). Defining conditions for biofilm inhibition and eradication assays for Gram-positive clinical reference strains.
Chicago
Shreya Shah, Päivi Tammela, and Cristina D. Cruz. 2018. “Defining Conditions for Biofilm Inhibition and Eradication Assays for Gram-Positive Clinical Reference Strains,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b700706924db4295a435f388a8a3c3b6&authtype=sso&custid=ns315887.